Metabolic profiles of human brain parenchyma and glioma for rapid tissue diagnosis by targeted desorption electrospray ionization mass spectrometry
Authors:
- 9 August 2021
- journal article
- research article
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 413 (25) , 6213-6224
Abstract
Desorption electrospray ionization mass spectrometry (DESI-MS) is well suited for intraoperative tissue analysis since it requires little sample preparation and offers rapid and sensitive molecular diagnostics. Currently, intraoperative assessment of the tumor cell percentage of glioma biopsies can be made by measuring a single metabolite, N-acetylaspartate (NAA). The inclusion of additional biomarkers will likely improve the accuracy when distinguishing brain parenchyma from glioma by DESI-MS. To explore this possibility, mass spectra were recorded for extracts from 32 unmodified human brain samples with known pathology. Statistical analysis of data obtained from full-scan and multiple reaction monitoring (MRM) profiles identified discriminatory metabolites, namely gamma-aminobutyric acid (GABA), creatine, glutamic acid, carnitine, and hexane-1,2,3,4,5,6-hexol (abbreviated as hexol), as well as the established biomarker NAA. Brain parenchyma was readily differentiated from glioma based on these metabolites as measured both in full-scan mass spectra and by the intensities of their characteristic MRM transitions. New DESI-MS methods (5 min acquisition using full scans and MS/MS), developed to measure ion abundance ratios among these metabolites, were tested using smears of 29 brain samples. Ion abundance ratios based on signals for GABA, creatine, carnitine, and hexol all had sensitivities > 90%, specificities > 80%, and accuracies > 85%. Prospectively, the implementation of diagnostic ion abundance ratios should strengthen the discriminatory power of individual biomarkers and enhance method robustness against signal fluctuations, resulting in an improved DESI-MS method of glioma diagnosis. Graphical abstractKeywords
Funding Information
- National Cancer Institute (IR33CA240181-01A1)
- Waters Technologies Corporation (40002775)
This publication has 60 references indexed in Scilit:
- N-Acetylaspartate (NAA) and N-Acetylaspartylglutamate (NAAG) Promote Growth and Inhibit Differentiation of Glioma Stem-like CellsJournal of Biological Chemistry, 2013
- GC/MS-based metabolomic analysis of cerebrospinal fluid (CSF) from glioma patientsJournal of Neuro-Oncology, 2013
- Potential of MR spectroscopy for assessment of glioma gradingClinical Neurology and Neurosurgery, 2013
- Desorption electrospray ionization mass spectrometry for lipid characterization and biological tissue imagingBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2011
- A short review on creatine–creatine kinase system in relation to cancer and some experimental results on creatine as adjuvant in cancer therapyAmino Acids, 2011
- Discrimination of Human Astrocytoma Subtypes by Lipid Analysis Using Desorption Electrospray Ionization Imaging Mass SpectrometryAngewandte Chemie International Edition, 2010
- High-throughput quantitative analysis by desorption electrospray ionization mass spectrometryJournal of the American Society for Mass Spectrometry, 2009
- Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trialThe Lancet Oncology, 2006
- Mass Spectrometry Sampling Under Ambient Conditions with Desorption Electrospray IonizationScience, 2004
- Course of brain shift during microsurgical resection of supratentorial cerebral lesions: limits of conventional neuronavigationActa Neurochirurgica, 2004